New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
08:15 EDTSIEGY, LIFE, BDX, ABT, RHHBY, ILMN, A, ENZ, LMNX, HOLX, AFFXEnzo Biochem announces August 18 as date of Markman hearing in lawsuit
Enzo Biochem (ENZ) announced today that U.S. District Judge Leonard P. Stark has established August 18th as the date for a patent claim construction hearing, also called a Markman hearing, involving Enzo Life Science’s U.S. Patents Nos. 6,992,180, 7,064,197, and 8,097,405. The hearing will be held in Delaware District Court. One or more of these patents is asserted against Abbott Labs (ABT), Affymetrix (AFFX), Agilent (A), Becton Dickinson (BDX), Gen-Probe, Hologic (HOLX), Illumina (ILMN), Life Technologies (LIFE), Luminex (LMNX), Roche (RHHBY), and Siemens (SIEGY), and their related entities. At such a hearing, the Judge will be asked to issue rulings regarding the language and interpretation of Enzo's patents at issue in the case. Markman hearings are considered a key event in a patent lawsuit. The upcoming Markman ruling will define the property rights for the technologies that Enzo has invented. Such rulings often drive and inform many aspects of the litigation.
News For ENZ;ABT;AFFX;A;BDX;HOLX;ILMN;LIFE;LMNX;RHHBY;SIEGY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
August 26, 2015
08:33 EDTLMNXLuminex submits 510(k) application for the NxTAG respiratory pathogen panel
Luminex has submitted a 510(k) application to the FDA for the company's NxTAG Respiratory Pathogen Panel, a respiratory assay that will enable laboratories to simultaneously detect 21 respiratory pathogens in a single closed tube system in a format that scales to changes in throughput requirements and responds to seasonal changes in demand.
07:28 EDTILMNIllumina added to Focus List at Citi
Subscribe for More Information
August 25, 2015
16:09 EDTBDXBecton Dickinson unit acquires Cellular Research to develop genomics platform
Subscribe for More Information
07:29 EDTBDXBecton Dickinson acquisition positive, says Stifel
Subscribe for More Information
05:09 EDTILMNIllumina enters oncology collaboration with Burning Rock
Subscribe for More Information
August 24, 2015
12:01 EDTRHHBYRoche buys nucleic acid purification technology from Lumora
Roche has signed a definitive asset purchase agreement with Lumora for products associated with the patent-protected Heat Elution technology for nucleic acid purification of multiple sample types including challenging formalin-fixed paraffin-embedded tumor samples. Roche plans to explore integrating this technology into its sequencing workflow solution.
08:29 EDTILMNWilliam Blair to hold a field trip
Subscribe for More Information
07:42 EDTSIEGYCerner should be bought with valuation at multi-year low, says Piper Jaffray
Subscribe for More Information
August 23, 2015
12:35 EDTRHHBYBiotech firms could see 'billions' in sales from new cancer drugs, Barron's says
Subscribe for More Information
August 21, 2015
09:38 EDTRHHBYUBS global healthcare analysts hold an analyst/industry conference call
Subscribe for More Information
August 19, 2015
06:08 EDTBDXFDA warns 'do not use' compounded drugs stored in BD 3ml, 5ml syringes
Subscribe for More Information
05:36 EDTILMNIllumina price target raised to $250 from $240 at Mizuho
Subscribe for More Information
August 18, 2015
05:25 EDTILMNIllumina, Warburg Pincus, Sutter Hill form Helix, announce collaborations
Illumina (ILMN), Warburg Pincus and Sutter Hill Ventures announced that they have formed a company to empower consumers to discover insights into their own genomes through a vibrant ecosystem of high-quality content partners. The company, called Helix, is based in the San Francisco Bay Area and received financing commitments in excess of $100M. Jay Flatley, CEO of Illumina, will serve as chairman. Helix will enable individuals to acquire an unprecedented amount of genetic information by providing affordable sequencing and database services for consumer samples brought through third party partners, driving the creation of an ecosystem of consumer applications. Helix also announced two collaborations today with major partners. First, the Center for Individualized Medicine at Mayo Clinic is collaborating with Helix to develop applications initially focused on consumer education and health-related queries. As part of the collaboration, Mayo Clinic also made a strategic investment in Helix. Second, Laboratory Corporation of America Holdings (LH) will develop and offer innovative analysis and interpretation services, initially focused on medically actionable genetic conditions, to consumers through Helix's platform. Helix expects that other partners will develop applications focused on areas such as genealogy, fitness or wellness, and inherited traits to enable insights related to an individual's genetics.
August 17, 2015
17:48 EDTAAgilent says confident in delivering on margin expansion goals
On the company Q3 earnings conference call, Agilent said that it is confident in delivering on margin expansion goals. The company noted that it is committed to a 22% operating margin by 2017 and will continue its buybacks in Q4. The company sees a number of areas of strength including Pharma, Life Science, Research and Diagnostics. The company is seeing double-digit growth in Pharma and has no reason to believe it will slow down. Agilent sees "a lot " of reasons to be positive on outlook.
16:21 EDTAAgilent says some U.S. and state government large deals delayed into Q4
Agilent said in a slides presentation that some US and state government large deals delayed into Q4. Customers in industrial markets continue cautious stance in light of macro-economic conditions.
16:09 EDTAAgilent narrows FY15 EPS view to $1.68-$1.72 from $1.67- $1.73
Subscribe for More Information
16:07 EDTAAgilent sees Q4 EPS 45c-49c, consensus 50c
Sees Q4 revenue $1.03B-$1.05B, consensus $1.06B.
16:06 EDTAAgilent reports Q3 EPS 44c, consensus 41c
Subscribe for More Information
14:48 EDTANotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Agilent (A), consensus 41c... Urban Outfitters (URBN), consensus 49c... MasTec (MTZ), consensus 15c... Fabrinet (FN), consensus 39c.
05:14 EDTRHHBYGenentech reports atezolizumab pivotal Phase II study met primary endpoint
Subscribe for More Information
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use